3-FMC
3-FMC is a synthetic stimulant of the substituted cathinone and phenethylamine classes.1 It is a structural isomer of flephedrone (4-fluoromethcathinone)1 and is pharmacologically related to mephedrone. 3-FMC has been distributed online as a designer drug, producing effects characteristic of its class.12 It may function as a monoamine releaser, reuptake inhibitor, or both.3 The substance is considered habit-forming and may carry significant addiction potential.
Contents
Dosage & Duration
Dosage
Rapid onset. 3-FMC is particularly harsh on nasal tissues.
Duration
Subjective Effects
3-FMC produces a classic synthetic cathinone stimulant experience centered on euphoria, mood lift, heightened energy, and a strong drive toward socializing and conversation. The experience carries a notable emotional volatility, with sociable enthusiasm capable of giving way to moodiness or aggression. Sensory alterations are largely absent at common doses, though visual and auditory hallucinations have been reported, typically in the context of heavy or sleep-deprived use.
Physical
Physical effects are typical of stimulants: increased energy and alertness, a reduced need for sleep, appetite suppression, sweating, jaw clenching, itchiness, and heightened libido. Disturbed sleep patterns and weight loss are associated with continued use.
Stimulation
Uncomfortable
Cognitive
The headspace is energetic and extroverted, marked by euphoria, an elevated mood, increased sociability, and excessive talkativeness. This can be accompanied by mood instability, with irritability or aggressive behavior emerging as less desirable counterparts to the initial mood lift.
Emotional
The emotional tone is initially elevated and enthusiastic but can be unstable.
Visual
Visual effects are not characteristic of typical use, though hallucinations have been reported at heavier levels of use.
Auditory
Auditory hallucinations have been reported alongside visual hallucinations.
Reagent Testing
Loading reagent data
Pharmacology
Pharmacodynamics
The precise mechanism of action of 3-FMC has not been well characterized. It may function as a monoamine releasing agent, a monoamine reuptake inhibitor, or both.3
Pharmacokinetics
Tolerance
Harm Potential
Addiction & Dependence
Psychological
Classified as habit-forming and may possess high addiction potential according to anecdotal reports, though this has not been scientifically verified.
Toxicity
Intranasal administration is reported to be very harsh on nasal membranes; occasional insufflation may cause irritation while frequent use could potentially cause more significant damage to nasal tissue.
Psychosis Risk
Visual and auditory hallucinations have been reported as effects, suggesting some potential for psychotomimetic effects, though the safety profile has not been scientifically studied.
History & Culture
3-Fluoromethcathinone emerged as part of the wave of novel cathinone designer drugs sold online, appearing alongside numerous other synthetic cathinones marketed as alternatives to controlled stimulants.1 As a structural isomer of flephedrone…
Legality
By Country
References
Source Pages
Citations
- (March 2009). Fluoromethcathinone, a new substance of abuse. Forensic Science International, 185(1–3), 10–20. https://doi.org/10.1016/j.forsciint.2008.11.0131234567
- Wojciuk B, Skonieczna-Zydecka K, Maciejewska D, Marlicz W, Grzywacz A, Drozd A, Bogacka I, Starzynska T, Kozlowska-Wiechowska A, Drozd P, Misiak B, Blazejczyk A, Kowalski P, Wesolowska J, & Marlicz P. (2018). The Designer Drug 3-Fluoromethcathinone Induces Oxidative Stress and Activates Autophagy in HT22 Neuronal Cells. https://pmc.ncbi.nlm.nih.gov/articles/PMC6154176/1
- Wojcieszak J, Andrzejczak D, Wojtas A, Pawlowski M, Budziszewska B, & Zawilska JB. (2019). Methcathinone and 3-Fluoromethcathinone Stimulate Spontaneous Horizontal Locomotor Activity in Mice and Elevate Extracellular Dopamine and Serotonin Levels in the Mouse Striatum. https://doi.org/10.1007/s12640-018-9973-412
- Meyer MR, Wilhelm J, Peters FT, & Maurer HH. (2012). New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine. https://doi.org/10.1002/jms.29601
- (n.d.). Anlage II BtMG – verkehrsfähige, aber nicht verschreibungsfähige Betäubungsmittel. Bundesministerium der Justiz / gesetze-im-internet.de. https://www.gesetze-im-internet.de/btmg_1981/anlage_ii.html12
- (n.d.). The Misuse of Drugs Act 1971 (Amendment) Order 2010 (SI 2010/1207). legislation.gov.uk. https://www.legislation.gov.uk/uksi/2010/1207/article/2/made12
- (n.d.). 21 CFR § 1308.11 – Schedule I. Legal Information Institute, Cornell Law School. https://www.law.cornell.edu/cfr/text/21/1308.111
Further Reading
Automated synthesisInformation aggregated and synthesized using an autonomous workflow built by Josie Kins.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the 3-FMC article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.